BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10411)

  • 21. Stability-indicating assay for phenylbutazone: high-performance liquid chromatographic determination of hydrazobenzene and azobenzene in degraded aqueous phenylbutazone solutions.
    Fabre H; Hussam-Eddine N; Mandrou B
    J Pharm Sci; 1984 Dec; 73(12):1706-9. PubMed ID: 6527240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acid-catalyzed decompostion of phenacylcobalamin: evidence for the formation of an enol-Co(III) pi-complex intermediate.
    Brown KL; Chu MM; Ingraham LL
    Biochemistry; 1976 Apr; 15(7):1402-7. PubMed ID: 4086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buffer-facilitated proton transport. pH profile of bound enzymes.
    Engasser JM; Horvath C
    Biochim Biophys Acta; 1974 Jul; 358(1):178-92. PubMed ID: 4850834
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanism of surface peptide proton exchange in bovine pancreatic trypsin inhibitor. Salt effects and O-protonation.
    Tüchsen E; Woodward C
    J Mol Biol; 1985 Sep; 185(2):421-30. PubMed ID: 2414452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation study of thiotepa in aqueous solutions.
    van Maanen MJ; Brandt AC; Damen JM; Beijnen JH
    Int J Pharm; 1999 Mar; 179(1):55-64. PubMed ID: 10053202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pH Dependence of the photocycle kinetics of the E46Q mutant of photoactive yellow protein: protonation equilibrium between I1 and I2 intermediates, chromophore deprotonation by hydroxyl uptake, and protonation relaxation of the dark state.
    Borucki B; Otto H; Joshi CP; Gasperi C; Cusanovich MA; Devanathan S; Tollin G; Heyn MP
    Biochemistry; 2003 Jul; 42(29):8780-90. PubMed ID: 12873139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution.
    Strickley RG; Brandl M; Chan KW; Straub K; Gu L
    Pharm Res; 1990 May; 7(5):530-6. PubMed ID: 2195493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of phenylbutazone and mofebutazone in the crystalline state and in solution.
    Paradies HH
    J Pharm Sci; 1987 Dec; 76(12):920-9. PubMed ID: 3440938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolysis of nicotinyl 6-aminonicotinate.
    Wang JC; Patel B
    J Pharm Sci; 1986 Feb; 75(2):204-7. PubMed ID: 3958934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of bacteriorhodopsin color by chloride at low pH. Significance for the proton pump mechanism.
    Renthal R; Shuler K; Regalado R
    Biochim Biophys Acta; 1990 Apr; 1016(3):378-84. PubMed ID: 2158820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of degradation products in a phenylbutazone tablet formulation.
    Matsui F; Robertson DL; Poirier MA; Lovering EG
    J Pharm Sci; 1980 Apr; 69(4):469-71. PubMed ID: 7373550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D(-)-N-Methylglucamine buffer for pH 8.5 to 10.5.
    Chromy V; Kulhánek V; Fischer J
    Clin Chem; 1978 Feb; 24(2):379-81. PubMed ID: 23911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of oxygen and sulfur effects on keto-enol chemistry in benzolactone systems: benzo[b]-2,3-dihydrofuran-2-one and -2-thione and benzo[b]-2,3-dihydrothiophene-2-one and -2-thione.
    Kresge AJ; Meng Q
    J Am Chem Soc; 2002 Aug; 124(31):9189-98. PubMed ID: 12149024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation kinetics of gonadorelin in aqueous solution.
    Hoitink MA; Beijnen JH; Bult A; van der Houwen OA; Nijholt J; Underberg WJ
    J Pharm Sci; 1996 Oct; 85(10):1053-9. PubMed ID: 8897270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational, kinetic, and NMR studies of the mechanism of E. coli GDP-mannose mannosyl hydrolase, an unusual Nudix enzyme.
    Legler PM; Massiah MA; Mildvan AS
    Biochemistry; 2002 Sep; 41(35):10834-48. PubMed ID: 12196023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uricase reaction intermediate. Mechanism of borate and hydroxide ion catalysis.
    Pitts OM; Priest DG
    Biochemistry; 1973 Mar; 12(7):1358-63. PubMed ID: 4696756
    [No Abstract]   [Full Text] [Related]  

  • 37. Ionization and tautomerization of 2-nitrocyclohexanone in aqueous solution.
    Angelini G; Maria PD; Fontana A; Pierini M; Siani G
    J Org Chem; 2007 May; 72(11):4039-47. PubMed ID: 17451273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrophotometric determination of dipyrone, phenylbutazone and oxyphenbutazone by their hydrolysis and Schiff base formation with 4-dimethylaminobenzaldehyde.
    Verma KK; Jain A; Patel N; Sanghi SK
    Farmaco Prat; 1987 Jul; 42(7):185-92. PubMed ID: 3622752
    [No Abstract]   [Full Text] [Related]  

  • 39. Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate.
    Borch RF; Getman KM
    J Med Chem; 1984 Apr; 27(4):485-90. PubMed ID: 6708050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferriprotoporphyrin and its imidazole complex in aqueous-ethanolic solution.
    Davies TH
    Biochim Biophys Acta; 1973 Nov; 329(1):108-17. PubMed ID: 4784482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.